Division of Allergy and Clinical Immunology,
Policlinico Umberto I, Rome
Italy
Review Article
Allergic Bronchopulmonary Aspergillosis: Diagnostic and Treatment Challenges
Author(s): Lucia Leonardi, Bianca Laura Cinicola, Rossella Laitano and Rossella LaitanoLucia Leonardi, Bianca Laura Cinicola, Rossella Laitano and Rossella Laitano
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens. ABPA diagnosis is defined by clinical, laboratory and radiological criteria including active asthma, immediate skin reactivity to A. fumigatus antigens, total serum IgE levels>1000 IU/mL, fleeting pulmonary parenchymal opacities and central bronchiectases that represent an irreversible complication of ABPA. Despite advances in our understanding of the role of the allergic response in the pathophysiology of ABPA, pathogenesis of the disease is still not completely clear. In addition, the absence of consensus regarding its prevalence, diagnostic criteria and staging limits the possibility of diagnosing the.. Read More»
DOI:
10.4172/2161-105X.1000361
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report